NasdaqGS - Nasdaq Real Time Price USD
Pacific Biosciences of California, Inc. (PACB)
At close: 4:00 PM EST
After hours: 5:13 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 6 | 10 | 10 |
| Avg. Estimate | -0.18 | -0.16 | -0.81 | -0.63 |
| Low Estimate | -0.21 | -0.19 | -0.89 | -0.76 |
| High Estimate | -0.11 | -0.13 | -0.74 | -0.53 |
| Year Ago EPS | -0.27 | -0.26 | -1.11 | -0.81 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 10 | 13 | 13 |
| Avg. Estimate | 40.71M | 43.08M | 155.54M | 192.22M |
| Low Estimate | 39.92M | 38.5M | 154.71M | 173M |
| High Estimate | 42M | 50M | 157.1M | 215M |
| Year Ago Sales | 58.36M | 38.81M | 200.52M | 155.54M |
| Sales Growth (year/est) | -30.24% | 10.99% | -22.43% | 23.58% |
Earnings History
| CURRENCY IN USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.28 | -0.26 | -0.22 | -0.22 |
| EPS Actual | -0.27 | -0.26 | -0.2 | -0.17 |
| Difference | 0.01 | 0 | 0.02 | 0.05 |
| Surprise % | 2.13% | 0.22% | 10.51% | 22.46% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.18 | -0.16 | -0.81 | -0.63 |
| 7 Days Ago | -0.2 | -0.17 | -0.89 | -0.68 |
| 30 Days Ago | -0.2 | -0.17 | -0.88 | -0.67 |
| 60 Days Ago | -0.2 | -0.17 | -0.88 | -0.66 |
| 90 Days Ago | -0.2 | -0.17 | -0.88 | -0.66 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 3 | 1 | 6 | 5 |
| Up Last 30 Days | 3 | 1 | 6 | 4 |
| Down Last 7 Days | 1 | -- | -- | 1 |
| Down Last 30 Days | 1 | -- | -- | 2 |
Growth Estimates
| CURRENCY IN USD | PACB | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 34.95% | -- | -- | 5.00% |
| Next Qtr. | 39.60% | -- | -- | 12.00% |
| Current Year | 26.67% | -- | -- | 2.10% |
| Next Year | 22.53% | -- | -- | 12.20% |
Upgrades & Downgrades
| Downgrade | UBS: Buy to Neutral | 11/11/2024 |
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 11/11/2024 |
| Maintains | Piper Sandler: Neutral to Neutral | 11/11/2024 |
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 8/28/2024 |
| Maintains | Stephens & Co.: Overweight to Overweight | 8/13/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 8/12/2024 |
Related Tickers
QSI Quantum-Si incorporated
0.6330
-4.22%
CERS Cerus Corporation
1.6800
+0.60%
NNOX Nano-X Imaging Ltd.
5.69
+0.18%
SENS Senseonics Holdings, Inc.
0.3177
+5.16%
BFLY Butterfly Network, Inc.
3.0500
+15.53%
DXCM DexCom, Inc.
74.88
-1.82%
TMDX TransMedics Group, Inc.
82.92
+2.46%
SINT Sintx Technologies, Inc.
3.2500
+2.20%
LAB Standard BioTools Inc.
1.5100
+0.67%
NUWE Nuwellis, Inc.
1.3400
-0.74%